ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AMPH Amphastar Pharmaceuticals Inc

43.91
0.39 (0.90%)
After Hours
Last Updated: 15:03:23
Delayed by 15 minutes

Period:

Draw Mode:

Volume 453,246
Bid Price 43.35
Ask Price 44.28
News -
Day High 44.83

Low
35.62

52 Week Range

High
67.66

Day Low 43.76
Share Name Share Symbol Market Stock Type
Amphastar Pharmaceuticals Inc AMPH NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.39 0.90% 43.91 15:03:23
Open Price Low Price High Price Close Price Previous Close
43.76 43.76 44.83 43.91 43.52
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
6,801 453,246 US$ 44.29 US$ 20,073,876 - 35.62 - 67.66
Last Trade Type Quantity Price Currency
15:33:20 1 US$ 44.28 USD

Amphastar Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.11B 48.10M - 644.4M 137.55M 2.86 15.34
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Amphastar Pharmaceuticals News

Date Time Source News Article
3/08/202415:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/08/202415:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/08/202415:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/06/202417:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/06/202416:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/06/202416:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/04/202419:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/01/202415:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
2/29/202415:53Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
2/28/202415:38Edgar (US Regulatory)Form 8-K - Current report
2/09/202416:21Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/02/202418:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No AMPH Message Board. Create One! See More Posts on AMPH Message Board See More Message Board Posts

Historical AMPH Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week44.2844.8342.83543.69339,286-0.37-0.84%
1 Month49.8150.3542.1645.08548,771-5.90-11.85%
3 Months61.6665.924942.1651.35492,639-17.75-28.79%
6 Months46.6165.924942.1652.45448,537-2.70-5.79%
1 Year37.6467.6635.6250.80450,1776.2716.66%
3 Years18.3167.6616.9138.55347,41925.60139.81%
5 Years20.5867.6612.32532.68296,41723.33113.36%

Amphastar Pharmaceuticals Description

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Your Recent History

Delayed Upgrade Clock